NCT00237666View on ClinicalTrials.gov

Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Bipolar II DisorderMajor Depressive Episode
Interventions
DRUG

Ziprasidone

Ziprasidone 20-60 mg BID, taken orally.

Trial Locations (2)

10024

Medical Research Network, L.L.C., New York

75024

The Mech Center, Plano

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Liebowitz, Michael R., M.D.

INDIV

collaborator

Pfizer

INDUSTRY

lead

The Medical Research Network

OTHER